Dr. Klaus F. Sellheyer, MD

Dr. Sellheyer practices at Florida Dermatology & Skin Cancer Centers in Winter Haven, Florida.

Dr. Sellheyer's NPI, 1730146564, was assigned on April 26, 2006. Dr. Sellheyer graduated from University of Gottingen Faculty of Medicine in 1985. Dr. Sellheyer holds Florida license ME85014.

Dr. Sellheyer's primary practice is Florida Dermatology & Skin Cancer Centers, at 1450 6th St Se, Winter Haven, FL 33880-4505. The practice phone is (863) 293-2147.

Dr. Sellheyer's primary practice is Florida Dermatology & Skin Cancer Centers in Winter Haven, Florida. The medical group on file is Florida Dermatology and Skin Cancer Centers.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Sellheyer practices. Vendor and product names are available with a free account.

Dermatopathology is Dr. Sellheyer's primary specialty in the NPI Registry, under taxonomy code 207ND0900X. Dr. Sellheyer is board certified in dermatology by the American Board of Dermatology. Dmand AI has Dr. Sellheyer's licenses on file in 15 states: Florida, California, Michigan, Arizona, Georgia, North Carolina, South Carolina, Tennessee, Pennsylvania, Delaware, Massachusetts, Maryland, New Jersey, New York and Illinois.

Dmand AI lists acne, acute skin infection, benign or precancerous skin growths, cold sores or genital herpes, contact dermatitis, facial skin infection, itchy rashes and minor injury to a limb among the conditions Dr. Sellheyer treats.

CMS data shows 12,003 Medicare services from Dr. Sellheyer across 24 procedure codes in 2024, for 4,396 Medicare patients. Medicare paid $621,549 for them. Every service was in an office.

CMS counts 4,396 Medicare patients who saw Dr. Sellheyer in 2024. The largest group is 75 to 84, with 1,830 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 2% are also on Medicaid. Their average risk score is 1.25, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Sellheyer's median patient age at 74, with 45% women.

In 2024, Dr. Sellheyer wrote 1,170 Medicare Part D claims for 578 patients. 96% of them were for generic drugs. CMS names the drug for 1,076 of them, across 13 drugs with 11 or more claims each, at $22,963 in total drug cost. In 2023, CMS named 1,124 claims across 10 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 75 out of 100 for Dr. Sellheyer for performance year 2024, reported individually. Dr. Sellheyer accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 227 procedures of skin biopsy by Dr. Sellheyer, more than 87% of the clinicians it reports for that procedure.

Dmand AI links 78 papers to Dr. Sellheyer, published from 2008 to 2014. 2009 was the busiest year, with 11. The most frequent topics are Skin Neoplasms, Hair Follicle and Skin. Dr. Sellheyer has published most often in J Cutan Pathol. Dr. Sellheyer's most frequent co-authors are Paula M. Nelson, MD, Wilma F. Bergfeld, MD and Dara Noelle Wakefield, MD.

CMS Open Payments shows 33 general payments to Dr. Sellheyer from 13 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 96% of the total. Galderma Laboratories, L.P. paid the most, $120.

Dr. Sellheyer graduated from University of Gottingen Faculty of Medicine in 1985.

Dr. Sellheyer is in network with 16 carriers, including Excellus BlueCross BlueShield, Elevance and United Healthcare. HMO plans come from the most carriers, 10. Check the plan with the practice before a visit.